Tier 2 — strong
[Effects of berberine on serum inflammatory factors and carotid atherosclerotic plaques in patients with acute cerebral ischemic stroke]
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
2016
41(21):4066-4071
Bibliography
- PubMed
- PMID 28929697
- Funding
- Funding was not established from the accessible source; this is not a declaration of no funding.
- Competing interests
- A complete competing-interest declaration was not available in the accessible source; no absence of conflicts is inferred.
Study snapshot
| Design | Randomized controlled human trial |
|---|---|
| Model | Human participants; see population |
| Sample | 120 acute ischemic stroke patients |
| Intervention | Berberine 300 mg three times/day plus standard care versus standard care |
| Duration | Inflammation at 14 days; plaque and disability outcomes at 90 days |
| Endpoints | Cardiac or vascular outcomes; Inflammatory biomarkers; Adverse events |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified
